Form Type: 4

SEC EDGAR Link
Accession Number:0001169245-21-000063
Date:2021-06-03
Issuer: PHASEBIO PHARMACEUTICALS INC (PHAS)
Original Submission Date:

Reporting Person:

HARRIGAN EDMUND
C/O PHASEBIO PHARMACEUTICALS, INC.
1 GREAT VALLEY PARKWAY, SUITE 30 MALVERN, PA 19355

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
NON-EMPLOYEE DIRECTOR STOCK OPTION (RIGHT TO BUY) 3.53 2021-06-03 deemed execution date A 14,000 (a) 2031-06-03 common stock 14,000 $3.53 14,000 direct
Footnotes
IDfootnote
f1 the shares subject to the option shall vest upon the earlier of the one year anniversary of the grant date or the 2022 annual meeting, subject to the reporting person's continuous service through each such date
WhaleWisdom Logo

Elevate your investments